Elizabeth G Bannister1, Donald J Cameron2, Jessica Ng3, Chung W Chow4, Mark R Oliver5, George Alex5, Anthony G Catto-Smith1, Ralf G Heine2, Annette Webb6, Kathleen McGrath6, Diane Simpson6, Winita Hardikar5. 1. 1] Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Parkville, Victoria, Australia [2] Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia. 2. 1] Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Parkville, Victoria, Australia [2] Murdoch Children's Research Institute, Parkville, Victoria, Australia. 3. Department of Anatomical Pathology, Royal Children's Hospital, Parkville, Victoria, Australia. 4. 1] Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia [2] Department of Anatomical Pathology, Royal Children's Hospital, Parkville, Victoria, Australia. 5. 1] Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Parkville, Victoria, Australia [2] Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia [3] Murdoch Children's Research Institute, Parkville, Victoria, Australia. 6. Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Parkville, Victoria, Australia.
Abstract
OBJECTIVES: Assessment of treatment response in children with celiac disease (CD) after commencing a strict gluten-free diet (GFD) is generally based on the resolution of clinical features and normalization of serology. Recent adult studies have shown that serologic markers do not correlate with mucosal recovery. We aimed (i) to determine whether anti-tissue transglutaminase immunoglobulin (Ig)A (tTG) and anti-deamidated gliadin peptide IgG (DGP) antibodies are sensitive and specific markers of mucosal recovery in children with CD on a GFD for at least 12 months, and (ii) to determine whether a validated dietary questionnaire of compliance can identify patients with mucosal recovery. METHODS: A total of 150 children with biopsy-proven CD were prospectively evaluated with duodenal biopsies at ≥12 months on GFD, paired with repeat tTG and DGP serology. The biopsies were reviewed in a blinded manner by two histopathologists and graded by Marsh criteria. A validated questionnaire of dietary compliance was also administered. RESULTS: Of 150 children recruited, 27 (18%) had positive serology, 97 (65%) had negative serology, and 26 (17%) had equivocal serology. Of the 97 children with negative serology, none had Marsh type 3 enteropathy. Of the 27 patients with positive serology, only 6 had Marsh type 3 changes. The sensitivity and specificity of serology as a marker of significant mucosal pathology was 75 and 85%, respectively, with a positive predictive value of 22% but a negative predictive value of 98%. Of the 129 (86%) questionnaires completed, 88% reported good or excellent compliance with a GFD (negative predictive value 97%). CONCLUSIONS: This study suggests that follow-up using two serological tests in children with CD on a GFD may obviate the need for repeat mucosal biopsy in the majority of patients. A standardized dietary questionnaire may be useful in identifying patients who require further evaluation.
OBJECTIVES: Assessment of treatment response in children with celiac disease (CD) after commencing a strict gluten-free diet (GFD) is generally based on the resolution of clinical features and normalization of serology. Recent adult studies have shown that serologic markers do not correlate with mucosal recovery. We aimed (i) to determine whether anti-tissue transglutaminase immunoglobulin (Ig)A (tTG) and anti-deamidated gliadin peptide IgG (DGP) antibodies are sensitive and specific markers of mucosal recovery in children with CD on a GFD for at least 12 months, and (ii) to determine whether a validated dietary questionnaire of compliance can identify patients with mucosal recovery. METHODS: A total of 150 children with biopsy-proven CD were prospectively evaluated with duodenal biopsies at ≥12 months on GFD, paired with repeat tTG and DGP serology. The biopsies were reviewed in a blinded manner by two histopathologists and graded by Marsh criteria. A validated questionnaire of dietary compliance was also administered. RESULTS: Of 150 children recruited, 27 (18%) had positive serology, 97 (65%) had negative serology, and 26 (17%) had equivocal serology. Of the 97 children with negative serology, none had Marsh type 3 enteropathy. Of the 27 patients with positive serology, only 6 had Marsh type 3 changes. The sensitivity and specificity of serology as a marker of significant mucosal pathology was 75 and 85%, respectively, with a positive predictive value of 22% but a negative predictive value of 98%. Of the 129 (86%) questionnaires completed, 88% reported good or excellent compliance with a GFD (negative predictive value 97%). CONCLUSIONS: This study suggests that follow-up using two serological tests in children with CD on a GFD may obviate the need for repeat mucosal biopsy in the majority of patients. A standardized dietary questionnaire may be useful in identifying patients who require further evaluation.
Authors: Jocelyn A Silvester; Satya Kurada; Andrea Szwajcer; Ciarán P Kelly; Daniel A Leffler; Donald R Duerksen Journal: Gastroenterology Date: 2017-05-22 Impact factor: 22.682
Authors: Maureen M Leonard; Dascha C Weir; Maya DeGroote; Paul D Mitchell; Prashant Singh; Jocelyn A Silvester; Alan M Leichtner; Alessio Fasano Journal: J Pediatr Gastroenterol Nutr Date: 2017-02 Impact factor: 2.839
Authors: Michelle S Lau; Peter D Mooney; William L White; Michael A Rees; Simon H Wong; Matthew Kurien; Nick Trott; Daniel A Leffler; Marios Hadjivassiliou; David S Sanders Journal: Am J Gastroenterol Date: 2017-10-10 Impact factor: 10.864
Authors: Isabel Comino; Fernando Fernández-Bañares; María Esteve; Luís Ortigosa; Gemma Castillejo; Blanca Fambuena; Carmen Ribes-Koninckx; Carlos Sierra; Alfonso Rodríguez-Herrera; José Carlos Salazar; Ángel Caunedo; J M Marugán-Miguelsanz; José Antonio Garrote; Santiago Vivas; Oreste Lo Iacono; Alejandro Nuñez; Luis Vaquero; Ana María Vegas; Laura Crespo; Luis Fernández-Salazar; Eduardo Arranz; Victoria Alejandra Jiménez-García; Marco Antonio Montes-Cano; Beatriz Espín; Ana Galera; Justo Valverde; Francisco José Girón; Miguel Bolonio; Antonio Millán; Francesc Martínez Cerezo; César Guajardo; José Ramón Alberto; Mercé Rosinach; Verónica Segura; Francisco León; Jorge Marinich; Alba Muñoz-Suano; Manuel Romero-Gómez; Ángel Cebolla; Carolina Sousa Journal: Am J Gastroenterol Date: 2016-09-20 Impact factor: 10.864
Authors: Zsolt Szakács; Péter Mátrai; Péter Hegyi; Imre Szabó; Áron Vincze; Márta Balaskó; Bernadett Mosdósi; Patrícia Sarlós; Mária Simon; Katalin Márta; Alexandra Mikó; Dániel Pécsi; Alexandra Demcsák; Judit Bajor Journal: PLoS One Date: 2017-11-02 Impact factor: 3.240